DXCM vs RGEN
Dexcom vs Repligen — AI-powered side-by-side comparison
| Metric | DXCM | RGEN |
|---|---|---|
| AI Score | 57 | 62 |
| Price | $83.46 | $141.09 |
| P/E Ratio | 32.22× | 190.55× |
| ROE | 0.3% | 0.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.5% |
| Debt / Equity | 0.51× | 0.33× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 77.2 | 50.9 |
| Beta | 1.4526 | 1.06 |
| Expected Upside | +5.8% | +5.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DXCM Full Analysis
RGEN Full Analysis